GSK PHARMACEUTICALS .(INDIA)

Pazopanib-votrient

“Pazopanib” is the Drug / Molecule content in "Votrient". Votrient is a multi-tyrosine kinase inhibitor of vascular endothelial growth factor receptor (VEGFR).Pazopanib blocks a number of proteins. It stops cancer cells forming blood vessels in order to grow.

Details
Specification

Indication

Votrient is indicated for the treatment of patients with advanced renal cell carcinoma (RCC) & soft tissue sarcoma (STS) who have received prior chemotherapy.

Note

Precaution

Votrient is a prescription drug and should be used under proper medical guidance and advice.
Monitor serum liver tests before initiation of treatment with Votrient
Blood pressure should be well controlled prior to initiating Votrient.
Votrient can cause fetal harm when administered to a pregnant woman.

Updated On Oct 30, 2019 by Admin